DK0588177T3 - Interferon-alpha/beta-bindende protein, fremstilling heraf samt farmaceutiske præparater indeholdende proteinet - Google Patents

Interferon-alpha/beta-bindende protein, fremstilling heraf samt farmaceutiske præparater indeholdende proteinet

Info

Publication number
DK0588177T3
DK0588177T3 DK93114084T DK93114084T DK0588177T3 DK 0588177 T3 DK0588177 T3 DK 0588177T3 DK 93114084 T DK93114084 T DK 93114084T DK 93114084 T DK93114084 T DK 93114084T DK 0588177 T3 DK0588177 T3 DK 0588177T3
Authority
DK
Denmark
Prior art keywords
protein
interferon
alpha
preparation
beta
Prior art date
Application number
DK93114084T
Other languages
Danish (da)
English (en)
Inventor
Daniela Novick
Menachem Rubinstein
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL103052A external-priority patent/IL103052A/en
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of DK0588177T3 publication Critical patent/DK0588177T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Transplantation (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK93114084T 1992-09-03 1993-09-02 Interferon-alpha/beta-bindende protein, fremstilling heraf samt farmaceutiske præparater indeholdende proteinet DK0588177T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL103052A IL103052A (en) 1992-09-03 1992-09-03 Soluble interferon-alpha receptors,their preparation and pharmaceutical compositions containing them
IL106591A IL106591A (en) 1992-09-03 1993-08-04 Interferon alpha/beta binding protein, its preparation and pharmaceutical compositions containing it

Publications (1)

Publication Number Publication Date
DK0588177T3 true DK0588177T3 (da) 2000-05-08

Family

ID=26322502

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93114084T DK0588177T3 (da) 1992-09-03 1993-09-02 Interferon-alpha/beta-bindende protein, fremstilling heraf samt farmaceutiske præparater indeholdende proteinet

Country Status (11)

Country Link
EP (1) EP0588177B1 (fr)
JP (3) JP3662264B2 (fr)
AT (1) ATE189262T1 (fr)
AU (1) AU674523B2 (fr)
CA (1) CA2105449C (fr)
DE (1) DE69327693T2 (fr)
DK (1) DK0588177T3 (fr)
ES (1) ES2142840T3 (fr)
GR (1) GR3032891T3 (fr)
IL (1) IL106591A (fr)
PT (1) PT588177E (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL108584A (en) * 1994-02-07 2008-03-20 Yeda Res & Dev Cloning of the interferon-binding protein ALPHA / BETA
US5821078A (en) 1992-09-03 1998-10-13 Yeda Research And Development Co. Ltd. Nucleic acid encoding interferon-α/β binding protein
IL107378A (en) * 1993-10-24 2005-05-17 Yeda Res & Dev SOLUBLE INTERFERON alpha-RECEPTOR, ITS PREPARATION AND USE
IL118096A0 (en) * 1996-05-01 1996-09-12 Yeda Res & Dev Antibodies against interferon alpha/beta receptor
EP0859633A2 (fr) * 1996-08-16 1998-08-26 Kurt B. Osther Procede de traitement des diabetes
US5989839A (en) * 1996-08-19 1999-11-23 Ghassan I. Shaker Use of MOLT4 CD69 expression to determine the presence and activity of interferon inhibitors
WO1999032141A1 (fr) 1997-12-19 1999-07-01 Applied Research Systems Ars Holding N.V. Complexe ifnar2/ifn
JP2008543335A (ja) * 2005-06-22 2008-12-04 ジェネンテック・インコーポレーテッド Ｉｆｎａｒ２を標的とするための方法と組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88377A (en) * 1988-11-14 1996-09-12 Yeda Res & Dev Cloning and expression of a protein which modulates cellular response to type I interferon
FR2657881A1 (fr) * 1990-02-05 1991-08-09 Europ Biotechnologie Lab Nouveaux polypeptides hydrosolubles, sequences d'adn, nouvelles cellules, procede de preparation, applications et compositions renfermant lesdits polypeptides.

Also Published As

Publication number Publication date
DE69327693D1 (de) 2000-03-02
EP0588177A2 (fr) 1994-03-23
EP0588177A3 (en) 1994-08-17
JP3907661B2 (ja) 2007-04-18
CA2105449A1 (fr) 1994-03-04
AU4609693A (en) 1994-03-10
PT588177E (pt) 2000-05-31
JP3662264B2 (ja) 2005-06-22
EP0588177B1 (fr) 2000-01-26
DE69327693T2 (de) 2000-09-07
ATE189262T1 (de) 2000-02-15
GR3032891T3 (en) 2000-07-31
JP2004254695A (ja) 2004-09-16
ES2142840T3 (es) 2000-05-01
AU674523B2 (en) 1997-01-02
IL106591A0 (en) 1993-12-08
JP2005162762A (ja) 2005-06-23
IL106591A (en) 2008-03-20
JPH06220100A (ja) 1994-08-09
CA2105449C (fr) 2010-07-20

Similar Documents

Publication Publication Date Title
DE69021387T3 (de) Medizinische aerosolformulierungen.
DE68924540T2 (de) Medizinische Aerosolformulierungen.
DE68905387T2 (de) Aminosäure-Nahrungsmittelzusammensetzungen.
FI921036A0 (fi) Tgf-b-proteinkompositioner foer inhibering av cellproliferation.
DK19991D0 (da) Proteinpraeparationer
FI864559A0 (fi) Nya insulinderivat och farmaceutiska preparat innehaollande dessa derivat.
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
DE3671446D1 (de) 5-aralkylsubstituierte 2h-benztriazole und stabilisierte zusammensetzungen.
MX9204240A (es) Montaje distribuidor y de mezclado de dos etapas para preparaciones tal como cementos dentales.
DK0588177T3 (da) Interferon-alpha/beta-bindende protein, fremstilling heraf samt farmaceutiske præparater indeholdende proteinet
DE69009795D1 (de) Muramylpeptid-Derivate und diese enthaltende immunregulierende Zusammensetzungen.
DK439589D0 (da) Fluorsubstituerede 4'-demethylepipodophyllotoksinderivater samt farmaceutiske praeparater indeholdende samme
NO874193D0 (no) Farmasoeytiske preparater.
DE3689767T2 (de) Immunverstärker und verwandte Zusammensetzungen.
FI923751A (fi) Hexahydrobenso/f/kinolinoner
FR2652742B1 (fr) Compositions anallergiques cosmetiques et dermo-pharmaceutiques.
IT8722397A0 (it) Composizioni cosmetiche.
AU2557288A (en) Synergistic antifungal protein and compositions containing same
MA21232A1 (fr) Compositions de shampooings.
BR9201408A (pt) Composto de dna,sequencia de dna,composto polipeptidico e composicao farmaceutica
IT1215261B (it) Composizioni farmaceutiche adattivita' antigalattopoietica.
ITMI932544A0 (it) Composizioni farmaceutiche e/o dermocosmetologiche e cosmetiche contenenti colostro bovino.
NO885269D0 (no) Proteinholdige sammensetninger.
IT1214187B (it) Composizioni farmaceutiche antimicotiche.
ITMI931417A0 (it) Composizioni farmaceutiche e/o dermocosmetologiche e cosmetiche contenenti colostro equino